financetom
Business
financetom
/
Business
/
Tata Power buzzing: Demand set to increase, says CEO Praveer Sinha
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Power buzzing: Demand set to increase, says CEO Praveer Sinha
Feb 26, 2021 5:20 AM

The Tata Power stock has been buzzing with big changes underway like distribution overtaking generation as the company's biggest business and solar power emerging as a new growth avenue. Praveer Sinha, MD and CEO of Tata Power discussed the power gameplan.

Share Market Live

NSE

In terms of demand, he expects to see huge traction in the coming months. “I think the demand has picked up a lot. We never used to see the demand for something like 180 gigawatts in the winter months. This time in the month of January we had something like 184-185 gigawatt, which is very strange. It demonstrates a huge industrial demand. Come summer, we definitely expect that the overall demand will go up. We will definitely see huge traction in the demand in coming months,” he said.

“I think the big change that we are seeing as announced by the Union Finance Minister Nirmala Sitharaman in her budget that the whole distribution business is getting de-licensed. That means you can have multiple supply companies who can supply electricity in any part of the country and you don’t need a license,” he stated.

“On distribution, we have got all the four distribution companies (DISCOMs) in Odisha and we have already taken over three of them and the fourth one we will do from April 1. That is a big boost to us,” he said.

“The bidding has happened for the two of the union territories. First was the Daman and Diu and second, was Chandigarh. Daman bids have been opened and the Chandigarh bid is expected to be opened in the next two-three weeks. We had not bid in Daman but we have definitely bid in Chandigarh and we are looking forward to getting the outcome of the bid process,” he added.

For entire conversation, watch the video

(Edited by : Abhishek Jha)

First Published:Feb 26, 2021 2:20 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's drivers fret as robotaxis pick up pace - and passengers
China's drivers fret as robotaxis pick up pace - and passengers
Aug 7, 2024
WUHAN (Reuters) - Liu Yi is among China's 7 million ride-hailing drivers. A 36-year-old Wuhan resident, he started driving part-time this year when construction work slowed in the face of a nationwide glut of unsold apartments. Now he predicts another crisis as he stands next to his car watching neighbours order driverless taxis. Everyone will go hungry, he said of...
Toyota cuts 2024 global vehicle output forecast by 5%, Chubu Keizai newspaper reports
Toyota cuts 2024 global vehicle output forecast by 5%, Chubu Keizai newspaper reports
Aug 7, 2024
TOKYO (Reuters) - Toyota Motor ( TM ) has downgraded its global vehicle production plan for the calendar year 2024 by about 5% due to output suspension at domestic factories, Chubu Keizai newspaper reported on Thursday. The Japanese automaker has told major suppliers its worldwide vehicle production is expected to be 9.8 million units, versus 10.3 million expected previously, the...
Brazil power firm Eletrobras posts almost-8% rise in 2nd-quarter net profit
Brazil power firm Eletrobras posts almost-8% rise in 2nd-quarter net profit
Aug 7, 2024
(Adds details and company comment on results details) SAO PAULO, Aug 7 (Reuters) - Brazilian power company Eletrobras on Wednesday reported a 7.6% increase in its second-quarter net profit from the same period a year earlier. The firm posted a net profit of 1.74 billion reais ($308.68 million) in the quarter ended in June. WHY IT'S IMPORTANT Eletrobras, which was...
UK's NHS to roll out Vertex/CRISPR gene therapy for rare blood disorder
UK's NHS to roll out Vertex/CRISPR gene therapy for rare blood disorder
Aug 7, 2024
Aug 7 (Reuters) - Britain's National Health Service (NHS) will begin to roll out a gene therapy from Vertex Pharmaceuticals ( VRTX ) and CRISPR Therapeutics to treat rare blood disorder beta thalassemia, Vertex said in a statement on Wednesday. Casgevy, which requires administration through authorized treatment centers with experience in stem cell transplantation, will be made available to eligible...
Copyright 2023-2026 - www.financetom.com All Rights Reserved